​

Funding Round

Seed Round - OneChain Immunotherapeutics

Seed Round - OneChain Immunotherapeutics

Investment Firm

Overview

OCI develops therapies for leukaemia based on CAR–T.

Announced Date

Jun 22, 2023

Funding Type

Seed

Highlights

Location

Europe

Social

Investor Lead

Invivo Capital Partners

Invivo Capital Partners

Invivo Capital Partners is a early_stage_venture and seed firm.

Participant Investors

5

Investor Name
Participant InvestorJosep Carreras Leukaemia Research Institute
Participant InvestorNara Capital
Participant InvestorInvivo Capital Partners
Participant InvestorClave Capital
Participant InvestorCentre for the Development of Industrial Technology (CDTI)

Round Details and Background

OneChain Immunotherapeutics raised $7340197 on 2023-06-22 in Seed Round

OCI develops therapies for leukaemia based on CAR–T.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 27, 2020
Seed Round - OneChain Immunotherapeutics
3-3.6M
Jun 22, 2023
Seed Round - OneChain Immunotherapeutics
5-7.3M

Recent Activity

There is no recent news or activity for this profile.